Pherecydes Pharma is a biotechnology company developing phage therapies for fighting bacterial infections that is headquartered in Romainville, France and was founded in 2006 by Jerome Gabard and Manuel Gea.
On December 1, 2014 Pherecydes Pharma completed their series A funding round with €1.9 million in funding from Auriga Partners.
On January 16, 2018 Pherecydes Pharma completed their series A funding round with €8.7 million in funding from Go Capital (lead investor), Omnes Capital, FaDiese, Auriga Partners, and ACE Management.
Timeline
Funding Rounds
Patents
Further Resources
Biotech raises funds to help produce phage therapies for bacterial infections
epmmagazine
Web
News
References
Organization
CompanyCompany attributes
Therapeutics
Phage therapy
Biomedical engineering
Biopharmaceutical
Microbiome
Technology
Biology
France
Romainville
B2B
Auriga Partners
Omnes Capital
CapDecisif Management
Go Capital
Karista
BiomX
Series B roundCategories
Related Topics
Contributors
- 1
Dawson Sewell
Writing about startups. - 2
Katrina-Kay Pettitt
Data Duchess @ Golden - 3
Elena Ruban
Freelancer now. Graduated from Financial University - 4
Meredith Hanel
Medical Genetics PhD, following life science applications that improve the health of humans and our planet. - 5
Erin Scherfner
loading information... - 6
Lax Mariappan
Technopreneur, Open source enthusiast, author, speaker. Co-founder of Eternus Global. Crafting applications for the medical industry. - 7
Neelam Jhaveri
Techno Geek + Gamer + Fashionista + Sense of Humor = It's ME - 8
Henry Ogolla
Passionate about reading and writing. - 9
Jessica Karpinski
I'm a knowledge seeker with a thirst to understand how the world is connected. - 10
Vlad Botushninu
I am a beginner programmer, I study IT sphere and cryptocurrencies